End-to-End R&D Documentation Acceleration
Power Nonclinical, Clinical, CMC, Safety, and Labeling documentation authoring with AI software that accelerates regulatory documents across all CTD modules from IND to NDA, across the drug lifecycle..
AuroraPrime RMA is an AI writing tool for end-to-end regulatory document automation in pharma, delivering up to 95% faster document authoring and lower manual costs for regulatory and medical writing teams.

Power Nonclinical, Clinical, CMC, Safety, and Labeling documentation authoring with AI software that accelerates regulatory documents across all CTD modules from IND to NDA, across the drug lifecycle..

Support all regulatory document types with an platform for pharma regulatory authoring that automates CTD and eCTD document creation, with cross-module connectivity.

Streamline timelines from first draft to final submission:

Accelerate clinical regulatory submissions by automating the authoring of critical-path documents, including pivotal CSRs, Clinical Overviews, and Clinical Summaries (Modules 2.7.3 & 2.7.4).
| Key Challenges | Data Fragmentation Delays Drafts | Post-Lock Pressure & QC Bottlenecks | Strategic Shifts Cause Inconsistencies |
AI Features |
First-Draft Automation & System Integration
|
Automated QC & Enterprise Review
|
Cross-Document Change Intelligent
|
Revenue Acceleration
Annual Revenue Growth
Automate the creation of critical Non-clinical, Clinical, CMC, Pharmacovigilance (PV), and Labeling documents across the entire drug R&D lifecycle.:

Our AI software automatically evaluates regulatory changes and conducts variation impact assessments across the entire CTD. Instantly visualize cross-document dependencies to streamline dossier updates and ensure compliance.

Automated diff detection connecting upstream data (e.g., Veeva RIM)


Automated dependency tracking & dynamic eCTD cross-referencing


Comprehensive variation impact analysis & authoring environment
Get product updates, industry insights, and the latest AuroraPrime news delivered to your inbox.
By submitting this form, I consent to receive communications from AlphaLife Sciences in accordance with our Privacy Policy.